Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone Augmentation of Nicotine Replacement Therapy
NCT02685072Phase 4Completed
- Sponsor
- Yale University
- Start
- Apr 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Crinone in nicotine dependence, sponsored by Yale University. Started Apr 2016; status: completed.
02
Drugs
Crinone
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02685072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02685072.